AV8 Ventures

Shennon Biotechnologies

San Francisco

ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8. www.shennonbio.com

Pulse

San Francisco

Pulse specializes in scalable extraction of structured data from complex documents for data infrastructure, using intelligent schema mapping and fine-tuned models to overcome legacy OCR failures. San Francisco-based, it serves Fortune 100 e

Clever Care Health Plan

Huntington Beach

Clever Care provides culturally sensitive, language-accessible healthcare that removes language barriers to timely and effective treatment and aligns its services with members’ needs.

Embrace

Connecticut

Embrace provides the only user-focused, mobile-first observability solution built on OpenTelemetry, linking mobile telemetry to backend insights to reveal real customer impact for SRE/DevOps teams.